Table I.
BPD severity | Definition (Modified from Jobe and Bancalari4) | Relative incidence (Data from Ehrenkranz et al5) | Postdischarge mortality (Data from Ehrenkranzet al5) |
---|---|---|---|
None | O2 treatment <28 d and breathing room air at 36 wk PMA or discharge home, whichever comes first | 23.1% | 1.8% |
Mild | O2 treatment at least 28 d and breathing room air at 36 wk PMA or discharge home, whichever comes first | 30.3% | 1.5% |
Moderate | O2 treatment at least 28 d and receiving <30% O2 at 36 wk PMA or discharge home, whichever comes first | 30.2% | 2.0% |
Severe (type 1) | O2 treatment at least 28 d and receiving ≥30% O2 or nasal CPAP/HFNC at ≥36 wk PMA | 16.4% | 4.8% |
Severe (type 2) | O2 treatment at least 28 d and receiving mechanical ventilation at ≥36 wk PMA. |
HFNC, high flow nasal cannula; O2, oxygen.